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ABSTRACT
Objective: To show the experience of the Erasto Gaertner Hospital with hemipelvectomy surgery over a 10-year period. Methods: 
This was a retrospective study on 32 patients who underwent hemipelvectomy at Erasto Gaertner Hospital between 1998 and 2008, 
assessing clinical and surgical characteristics. Results: Among the 32 patients, 15 were female and 17 were male. The mean age 
was 37.94 years. Eight cases showed involvement of the neurovascular bundle: three were located in the iliac and extended to 
the thigh, two were in the acetabulum and extended to the thigh and three were in the acetabulum and pubis. Twenty-three cases 
presented a neurovascular bundle free from neoplasia: 11 were restricted to the iliac, six were in the acetabular region, two were 
in the pubic ramus and four extended to the whole hemipelvis bone. One case involved the iliac-femoral vessels: one in the pubic 
ramus. Seven cases of chondrosarcoma and four cases of Ewing’s sarcoma represented the majority. Eight cases underwent external 
hemipelvectomy and 24 underwent internal hemipelvectomy (11 were type I; four were type II; two were type II + III; three were 
type III and four were type IV). Of these 24 cases, 13 did not have any reconstruction, 10 had a fibular graft and one had an iliac-
femoral vein and artery prosthesis. Twenty-six surgeries were curative and six were palliative. There were 14 deaths. Survival of 
two and five years was seen in 11 and 10 cases, respectively. For six cases, less than two years had passed since the operation. 
Three cases were lost during follow-up. Conclusion: This study shows the experiences of an oncology reference service specializing 
in highly complex surgical treatment.
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INTRODUCTION
The bones of the pelvic region are the site for less 
than 5% of all malignant bone tumors. Despite this ra-
rity, they constitute a separate chapter regarding bone 
tumor treatment because of the e anatomical complexity 
of this region. They therefore remain a problem that is 
difficult to solve, even today(1,2).
External hemipelvectomy (resection of entire hemi-
pelvis, including the lower limb) is especially indicated 
for patients with extensive tumors that compromise the 
hemipelvis with involvement of the root of the thigh. 
However, with the development of new chemotherapy 
drugs, radiotherapy, diagnostic methods and surgical 
techniques, increasing numbers of patients have been 
undergoing limb-preserving surgery (internal hemipel-
vectomy)(1-4). Provided that a good oncological resection 
margin is possible without amputation, preserving sur-
gery is indicated with the aim of obtaining oncological 
results similar to those obtained through external hemi-
pelvectomy. Occasionally, hemipelvectomy with pallia-
tive intent is performed with the aim of providing local 
control when other, less aggressive therapeutic methods 
that were indicated earlier, such as radiotherapy, che-
motherapy, antibiotics and powerful analgesics, among 
others, have not given rise to the desired effect(3).
The aim of the present study was to show the ex-
perience of Erasto Gaertner Hospital, in Curitiba, with 
pelvic belt surgery between 1998 and 2008.
© 2010 Sociedade Brasileira de Ortopedia e Traumatologia. Open access under CC BY-NC-ND license.
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PATIENTS AND METHODS
Thirty-two patients who underwent hemipelvectomy 
at Erasto Gaertner Hospital, in Curitiba, between 1998 
and 2008, were retrospectively studied, and their clinical 
and surgical characteristics were assessed.
RESULTS
Among the 32 patients, the minimum age was nine ye-
ars, the maximum was 73 and the mean was 37.94 years.
Fifteen cases were females and 17 were males.
Eight cases presented tumor invasion of the neu-
rovascular bundle: three were located in the iliac and 
extended to the thigh, two were in the acetabulum and 
extended to the thigh and three were in the acetabulum 
and pubis (Figure 1). Twenty-three cases did not pre-
sent any tumor invasion of the neurovascular bundle: 
11 were restricted to the iliac, six were in the acetabular 
region, two were in the pubic ramus and four extended 
to the whole hemipelvis bone (Figure 2). One patient 
presented a tumor in the region of the pubic ramus 
that compromised the femoral artery and vein without 
neural involvement.
vein and artery prosthesis. Among the 10 cases with a 
fibular graft, four underwent hemipelvectomy type IV, 
Figure 3 – Type of hemipelvectomy
Box 1 – Histopathology
Histological type N
Adenocarcinoma 2
Squamous cell carcinoma 1
Chondrosarcoma 7
Malignant fibrohistiocytoma 3
Hemangiosarcoma 1
Osteosarcoma 3
PNET 2
Alveolar rhabdomyosarcoma 1
Embryonic rhabdomyosarcoma 1
Ewing’s sarcoma 4
Pleomorphic and spindle cell sarcoma 2
Synovial sarcoma 3
Giant cell tumor 2
Total 32
Among the 24 cases that underwent internal hemi-
pelvectomy, 13 (54%) did not undergo reconstruction, 
10 (42%) underwent insertion of a fibular graft and one 
case (4%) required a graft consisting of an iliac-femoral 
Figure 1 – Locations of the tumors with neurovascular bundle 
involvement
Figure 2 – Locations of the tumors without neurovascular bundle 
involvement
The smallest tumor diameter was 8 cm and the ma-
ximum was 30 cm, with a mean of 16.13 cm.
With regard to histological type, the largest num-
ber (seven cases) consisted of chondrosarcoma, while 
Ewing’s sarcoma was in second place (four cases). The 
other histological types are described in Box 1.
Among the 32 patients, eight cases (25.1%) underwent 
external hemipelvectomy: six with reconstruction using 
a posterior gluteal flap and two with an anterior myocu-
taneous flap from the thigh (Figures 3 and 4).
Twenty-four cases (75%) underwent internal hemi-
pelvectomy, distributed thus according to the Enneking 
classification: 11 type I, four type II, two type II + III, 
three type III and four type IV (Figure 5).
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two type II + III and four type II (Figure 6).
The patient who underwent the graft of iliac-femoral 
vessels presented tumor formation with direct infiltra-
tion of the iliac-femoral vein and artery, without nerve 
involvement, and underwent hemipelvectomy type III 
with en-bloc resection of these vessels together with the 
tumor and reconstruction using PTFE prostheses for the 
vein and artery.
(R1 resection). All these cases underwent adjuvant tre-
atment with radiotherapy and chemotherapy, without 
undergoing a new surgical intervention. The types of 
hemipelvectomy, survival and histological types of these 
tumors are specified in Box 3.
Figure 4 – Type of reconstruction in cases of external hemipel-
vectomy
Figure 5 – Type of internal hemipelvectomy
Figure 6 – Reconstruction in cases of internal hemipelvectomy
Figure 7 – Intention: curative versus palliative
Figure 8 – Complications
Out of the 32 patients, 26 cases (81.3%) were opera-
ted with curative intent and six (18.8%) with palliative 
intent (Figure 7).
In 24 cases (75%), the surgery did not present com-
plications. In five cases (15.6%), there was infection of 
the operative wound; in two (6%), hematoma; and in 
one (3.1%), partial necrosis of the graft (Figure 8).
In the present study, no local recurrence was observed. 
The rate of distant recurrence was 21.8% (Box 2).
With regard to the surgical margins, 12.5% presen-
ted margins that were microscopically compromised 
Box 3 – Types of hemipelvectomy, survival and histological type 
of the tumors with R1 resection
One 
case
Type I internal 
hemipelvectomy
Death one year later Ewing’s sarcoma
One 
case 
Type IV internal 
hemipelvectomy
Death five months 
later
Chondrosarcoma
One 
case 
Type I internal 
hemipelvectomy 
Lost from follow-up 
eight years later
Chondrosarcoma
One 
case 
Type I internal 
hemipelvectomy 
Surgery two months 
later
Malignant 
fibrohistiocytoma
Box 2 – Deaths among patients with distant recurrence
One case six months later LUNG – Death one year later
One case five years later LUNG – Death five years later
Two cases one year later
LUNG – One lost from follow-up; the other died 
two years later
One case seven months later LUNG – Death one year later
One case two months later SPINE – Death three months later
One case four months later SPINE – Death five months later
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Over the period studied, there were 14 cases (44%) 
of death and three cases (9%) of loss from the follow-
up (Figure 9). The minimum length of survival was one 
day, the maximum was five years and the mean was 
10.6 months. Among these 14 deaths, four were patients 
who had undergone palliative surgery, and they died as 
a direct consequence of the disease (Box 4). The other 
10 patients died due to causes unrelated to the surgical 
intervention, and none of the reported surgical compli-
cations had any impact on the patients’ survival.
With regard to the functional point of view of the pa-
tients who underwent hemipelvectomy, the 15 surviving 
cases were interviewed recently for the present study, 
in order to ascertain their satisfaction with the surgery. 
The final result was based on the functional staging ac-
cording to Enneking, as adopted by the Musculoskeletal 
Tumor Society. This classification is as follows:
Excellent: no pain, functions without restrictions, and 
excellent acceptance by the patient;
Good: low-intensity non-incapacitating pain and/or 
restrictions on recreation functions, and good acceptan-
ce by the patient;
Regular: moderate pain with intermittent incapacita-
tion and/or partial occupational restriction, and regular 
acceptance by the patient;
Poor: high-intensity pain with continuous incapaci-
tation, and/or total occupational restriction, and patient 
dissatisfaction.
The data obtained are shown in Figure 12.
Figures 13, 14 and 15 show, respectively: the time of 
the surgery, with reconstruction using the fibula in type 
IV internal hemipelvectomy; vascular reconstruction of 
the iliac-femoral vein and artery, in internal hemipelvec-
tomy; and the final appearance of the lower limbs of the 
patient who underwent vascular reconstruction.
Box 4 – Survival among patients who underwent palliative 
hemipelvectomy
One case One day
One case Two months
One case Three months
One case Five months
Two cases Lost from follow-up
Figure 12 – Overall functional result, in accordance with the 
categories of the classification of Enneking et al (1993), among 
patients who underwent hemipelvectomy
Figure 10 – Two-year survival
Figure 11 – Five-year survival
Figure 9 – Death
Two years of survival was observed in 11 cases 
(34.4%), six cases (18.8%) had had recent surgery (less 
than two years of follow-up) and three cases (9.4%) 
were lost from the follow-up (Figure 10). None of the 
cases with distant recurrence survived for two years.
Five years of survival was observed in 10 cases 
(31.3%), six cases (18.8%) had had recent surgery (less 
than five years of follow-up) and three cases (9.4%) 
were lost from the follow-up (Figure 11). None of the 
cases with distant recurrence survived for five years.
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DISCUSSION
Despite all the development of oncological surgery, 
resection of pelvic tumors is one of the problems that have 
undergone most changes in limb-preserving surgery.
The malignant tumors most commonly encountered 
in the pelvic region are, in order of frequency, chon-
drosarcoma, Ewing’s sarcoma and osteosarcoma(3). In 
our study, the majority consisted of chondrosarcoma 
and, in second place, Ewing’s sarcoma; these data 
agree with the literature.
The type of surgery (external or internal hemipelvec-
tomy) is based on the size of the tumor and/or the lo-
cation of the adjacent structures and tissues involved(5). 
Extensive tumors of the pelvic region that invade bones, 
soft tissues, nerves and vessels are difficult to treat con-
servatively. External hemipelvectomy is a procedure 
with considerable morbidity and is today only indicated 
for a small proportion of pelvic tumors, when the ex-
tent of the tumor and the involvement of the root of the 
thigh and the neurovascular bundle make it impossible 
to preserve the limb. In such cases, it may be the only 
alternative for resection of these tumors with adequate 
margins and an acceptable disease-free interval. In a 
standard external hemipelvectomy procedure, a gluteal 
myocutaneous flap is the reconstruction most used. For 
extensive gluteal tumors or tumors of the posterior pro-
ximal region of the thigh that require hemipelvectomy 
for treatment, an anterior myocutaneous flap from the 
thigh, maintained using femoral veins, is without doubt 
the most appropriate and safest option(6,7). In our study, 
out of the 32 patients, eight (25.1%) underwent external 
hemipelvectomy (six with a gluteal flap and two with an 
anterior myocutaneous flap from the thigh).
Internal hemipelvectomy is a complex procedure but 
cosmetically superior to external hemipelvectomy. It is 
indicated for smaller tumors that are restricted to the 
hemipelvis, without compromising the thigh and wi-
thout neurovascular invasion of the iliofemoral bundle. 
In cases in which there is vascular invasion, without 
neural involvement, surgery may be indicated with re-
Figure 13 – Reconstruction using fibula in case of type IV internal 
hemipelvectomy
Figure 14 – Vascular reconstruction of iliac-femoral vein and 
artery in case of internal hemipelvectomy
Figure 15 – Final appearance of lower limbs of patient who un-
derwent vascular reconstruction
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construction of the artery and/or vein with a vascular 
prosthesis, in order to keep the ipsilateral lower limb 
functional(8). In our study, one of the cases underwent 
associated vascular reconstruction.
The type of internal hemipelvectomy according to 
the Enneking classification is based on the location of 
the tumor in the pelvis: type I (wing of the iliac), type 
II (periacetabular region), type III (pubic arch) and type 
IV (entire bone of the hemipelvis). In our study, 24 cases 
(75%) underwent internal hemipelvectomy: 11 cases of 
type I, two of type II + III, four of type II, three of type 
III and four of type IV.
One point that remains controversial in the literature is 
the question of reconstruction in cases of internal hemi-
pelvectomy. In a study retrospectively evaluating 31 cases 
(12 at the AC Camargo Hospital in São Paulo and 19 at 
the Boldrini Hospital in Campinas) that underwent type 
II hemipelvectomy, with or without reconstruction of the 
pelvic ring using the fibula, the patients who underwent 
internal hemipelvectomy with reconstruction of the pelvic 
ring using an autograft from the fibula had better overall 
functional results than shown by the group that did not 
undergo reconstruction (p = 0.007)(9). In our study, out of 
the 24 cases that underwent internal hemipelvectomy, 10 
(42%) received a fibular graft: four type IV, two type II 
+ III and four type II. No comparative functional study 
between the two groups was made at our service.
In the literature, two non-consensual strands can be 
seen in relation to indications for pelvic reconstruction 
after internal hemipelvectomy:
Surgeons who have not indicated pelvic reconstruc-
tion have emphasized the difficulty in making surgical 
approaches to the pelvis, because of the proximity to 
organs and neurovascular bundles. Guest et al(10) men-
tioned that reconstruction of the acetabulum was as 
difficult as the removal of the tumor. Veth et al(11) em-
phasized the fact that after resection of the pelvic tumor, 
the hip and lower-limb function would never be normal, 
independent of the reconstruction performed. These au-
thors published satisfactory functional results from pa-
tients without reconstruction. Another point considered 
by Hugate and Sim(12) was the duration of the operation 
and the blood loss, which are less in operations without 
reconstruction. It is important to note that, for patients 
who undergo type I resection (iliac wing lesions) or 
type III resection (lesions in the ischiopubic region), re-
construction is not necessary because the biomechanical 
change that is caused does not lead to any considerable 
functional loss(12).
Surgeons who advocate reconstruction justify this 
in terms of the possibility of restoring pelvic stability, 
maintaining hip mobility, minimizing the discrepancy in 
leg length and, consequently, obtaining better functional 
and esthetic results(13,14).
Nevertheless, there is still no consensus regarding 
whether or not to reconstruct the pelvis after tumor re-
section. It has not been defined which type of surgery 
would bring greatest benefit to patients. Several studies 
have been conducted over recent decades, and each of 
them has presented advantages and disadvantages of a 
variety of surgical techniques relating to resection of 
pelvic tumors.
Certain other points also remain controversial. The 
first of these is postoperative disease control and survi-
val. Studies have shown that after resection consisting 
of hemipelvectomy for high-grade sarcomas, the survi-
val rate has ranged up to 40%, with local recurrence of 
70%(8,15). In our study, considering the different histolo-
gical types, the mean length of survival was 10.6 mon-
ths, and the two and five-year survival rates were 34.4% 
and 31.3%, respectively. Local recurrence, which is one 
of the main complications, with an important impact 
on survival, was not observed in our study. The second 
point concerns the high complication rate reported in 
relation to these extensive and complex surgical pro-
cedures. Among the most common of these complica-
tions are superficial and deep infections, seroma, suture 
dehiscence, loosening of fibular grafts, neuropraxia and 
venous thrombosis. Infections and nerve lesions, among 
others, can reach incidence of 50%(5,8,16). In our study, 
there were no complications in 75% of the patients, 
while superficial infection of the operative wound oc-
curred in 15.6%, superficial subcutaneous hematomas 
in 6% and partial graft necrosis in 3.1%. None of these 
complications required a new surgical intervention, and 
they were treated using antibiotic therapy, outpatient 
drainage of the superficial hematoma in the operative 
wound and debridement of the edges of the operative 
wound, respectively. No cases of loosening of fibular 
grafts, severe neuropraxia, thrombosis or other, more 
severe complications were observed.
Palliative hemipelvectomy has been indicated for 
patients with metastatic or locally advanced bone 
disease(17,18). The indications include intractable pain, 
ulceration, hemorrhage, infection and unstable patholo-
gical fracture; however, there is still no consensus in the 
literature regarding this indication. Because palliative 
hemipelvectomy is controversial, especially in cases 
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with less than one year of survival, it is of utmost im-
portance to evaluate other options before surgery(17,18). 
In our study, six patients were operated with palliative 
intent. Among these, the survival was one, 60, 90 and 
180 days among the patients who continued with the 
follow-up, while two cases were lost from the follow-
up and their survival could therefore not be determined. 
The final analysis on the improvement of quality of life 
achieved through the surgery was not quantified through 
standardized questionnaires. Thus, because of the retros-
pective design of this study, we were unable to come to 
conclusions regarding the results attained through the 
palliative indication. Nonetheless, it is worth empha-
sizing that the indications were based on the patients’ 
symptoms of worsening pain, infection and local blee-
ding that were unresponsive to drug treatment and ra-
diotherapy, with a desire to undergo surgery mentioned 
by the patient, who was made aware of the impossibility 
of a cure and the extend of the procedure.
With regard to the functional results, in several cases 
they have been good and encouraging, even allowing 
some patients to walk without the aid of crutches or 
sticks and allowing single-leg loading of body weight. 
Some patients have required several months for reha-
bilitation but have achieved the possibility of walking 
without crutches, while others have been able to walk 
without any type of orthosis(17-20). However, because of 
the retrospective nature of most of these studies, it is di-
fficult to quantify and qualify the degree of control over 
the symptoms that was achieved. The functional evalu-
ation in the present study was made using the Enneking 
staging system(21), as adopted by the Musculoskeletal 
Tumor Society. Through this classification, among the 
15 surviving patients who we recently interviewed for 
this study regarding the functioning of the operated 
limb, three said that the result was excellent, eight said 
that it was good and four said that it was regular. These 
last four patients said that the result was regular because 
they needed to use crutches to carry out their habitual 
activities, but for less than 50% of the time.
In conclusion, this study showed that hemipelvec-
tomy is a viable surgical procedure because of the 
low incidence of postoperative complications and 
the absence of local recurrence in our sample. The 
percentages that we obtained were lower than in the 
literature. The type of hemipelvectomy indicated de-
pends essentially on the local extent of the disease. For 
patients for whom a cure is not expected, prospective 
studies on quality of life are needed in order to vali-
date this surgical procedure, taking into consideration 
patients’ wished, the local conditions of the tumor and 
the previous treatments carried out.
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